Ad is loading...
COEP
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
SCNI
Price
$3.54
Change
+$0.52 (+17.22%)
Updated
Nov 22 closing price
Ad is loading...

COEP vs SCNI

Header iconCOEP vs SCNI Comparison
Open Charts COEP vs SCNIBanner chart's image
Coeptis Therapeutics Holdings
Price$0.19
Change-$0.00 (-0.00%)
Volume$268.29K
CapitalizationN/A
Scinai Immunotherapeutics
Price$3.54
Change+$0.52 (+17.22%)
Volume$40.77K
CapitalizationN/A
COEP vs SCNI Comparison Chart
Loading...
COEP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
COEP vs. SCNI commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a Buy and SCNI is a Hold.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (COEP: $0.19 vs. SCNI: $3.54)
Brand notoriety: COEP and SCNI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 85% vs. SCNI: 121%
Market capitalization -- COEP: $8M vs. SCNI: $3.02M
COEP [@Biotechnology] is valued at $8M. SCNI’s [@Biotechnology] market capitalization is $3.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $450.11B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 1 FA rating(s) are green whileSCNI’s FA Score has 1 green FA rating(s).

  • COEP’s FA Score: 1 green, 4 red.
  • SCNI’s FA Score: 1 green, 4 red.
According to our system of comparison, both COEP and SCNI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 5 TA indicator(s) are bullish while SCNI’s TA Score has 4 bullish TA indicator(s).

  • COEP’s TA Score: 5 bullish, 5 bearish.
  • SCNI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, COEP is a better buy in the short-term than SCNI.

Price Growth

COEP (@Biotechnology) experienced а -2.21% price change this week, while SCNI (@Biotechnology) price change was +24.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

COEP is expected to report earnings on Mar 29, 2023.

SCNI is expected to report earnings on May 02, 2023.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COEP($8M) has a higher market cap than SCNI($3.02M). SCNI YTD gains are higher at: -40.544 vs. COEP (-75.175). SCNI has higher annual earnings (EBITDA): -7M vs. COEP (-10.29M). SCNI has more cash in the bank: 3.08M vs. COEP (1.14M). COEP has less debt than SCNI: COEP (1.78M) vs SCNI (20.8M). SCNI has higher revenues than COEP: SCNI (284K) vs COEP (0).
COEPSCNICOEP / SCNI
Capitalization8M3.02M265%
EBITDA-10.29M-7M147%
Gain YTD-75.175-40.544185%
P/E RatioN/AN/A-
Revenue0284K-
Total Cash1.14M3.08M37%
Total Debt1.78M20.8M9%
FUNDAMENTALS RATINGS
COEP vs SCNI: Fundamental Ratings
COEP
SCNI
OUTLOOK RATING
1..100
5177
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8887
P/E GROWTH RATING
1..100
10094
SEASONALITY SCORE
1..100
55n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COEP's Valuation (26) in the null industry is in the same range as SCNI (33) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to SCNI’s over the last 12 months.

COEP's Profit vs Risk Rating (100) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to SCNI’s over the last 12 months.

COEP's SMR Rating (99) in the null industry is in the same range as SCNI (100) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to SCNI’s over the last 12 months.

SCNI's Price Growth Rating (87) in the Pharmaceuticals Major industry is in the same range as COEP (88) in the null industry. This means that SCNI’s stock grew similarly to COEP’s over the last 12 months.

SCNI's P/E Growth Rating (94) in the Pharmaceuticals Major industry is in the same range as COEP (100) in the null industry. This means that SCNI’s stock grew similarly to COEP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPSCNI
RSI
ODDS (%)
Bearish Trend 1 day ago
28%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
54%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
22%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
COEP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SCNI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARRY6.630.30
+4.74%
Array Technologies
DUOL351.9710.37
+3.04%
Duolingo
OFIX18.910.23
+1.23%
Orthofix Medical
YCBD0.46N/A
+0.02%
cbdMD
CNTX1.39-0.11
-7.33%
Context Therapeutics

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with SNPX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
+2.47%
SNPX - COEP
37%
Loosely correlated
+1.36%
LOGC - COEP
35%
Loosely correlated
+2.01%
SCNI - COEP
31%
Poorly correlated
+17.22%
TIL - COEP
31%
Poorly correlated
+5.61%
YMAB - COEP
30%
Poorly correlated
+3.07%
More

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with SNPX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then SNPX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
+17.22%
SNPX - SCNI
73%
Closely correlated
+1.36%
ACHL - SCNI
45%
Loosely correlated
-0.93%
SYRE - SCNI
43%
Loosely correlated
+2.59%
MBIO - SCNI
38%
Loosely correlated
-1.35%
BIVI - SCNI
34%
Loosely correlated
-1.93%
More